Traws Pharma, Inc.TRAWNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+238.2%
5Y CAGR+32.0%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+238.2%/yr
vs -55.6%/yr prior
5Y CAGR
+32.0%/yr
Recent acceleration
Acceleration
+293.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q2 2025 | 98.75% |
| Q4 2024 | -48.82% |
| Q2 2024 | 44.26% |
| Q4 2023 | 11.14% |
| Q2 2023 | 7.54% |
| Q4 2022 | -32.69% |
| Q2 2022 | 1.65% |
| Q4 2021 | 32.93% |
| Q2 2021 | 42.99% |
| Q4 2020 | 8.35% |
| Q2 2020 | 90.58% |
| Q4 2019 | 57.66% |
| Q2 2019 | 2.55% |
| Q4 2018 | 68.46% |
| Q2 2018 | 68.29% |
| Q4 2017 | 14.94% |
| Q2 2017 | -38.62% |
| Q4 2016 | -494.17% |
| Q2 2016 | -248.92% |
| Q4 2015 | 86.53% |
| Q2 2015 | 24.65% |
| Q4 2014 | 20.57% |
| Q2 2014 | 18.35% |
| Q4 2013 | -27.85% |
| Q2 2013 | -107.38% |
| Q4 2012 | 35.78% |
| Q2 2012 | 0.00% |